2003
DOI: 10.1152/japplphysiol.00634.2003
|View full text |Cite
|
Sign up to set email alerts
|

Exogenous NO administration and α-adrenergic vasoconstriction in human limbs

Abstract: Nitric oxide (NO) is capable of blunting alpha-adrenergic vasoconstriction in contracting skeletal muscles of experimental animals (functional sympatholysis). We therefore tested the hypothesis that exogenous NO administration can blunt alpha-adrenergic vasoconstriction in resting human limbs by measuring forearm blood flow (FBF; Doppler ultrasound) and blood pressure in eight healthy males during brachial artery infusions of three alpha-adrenergic constrictors (tyramine, which evokes endogenous norepinephrine… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
37
0

Year Published

2004
2004
2025
2025

Publication Types

Select...
5
2
1

Relationship

1
7

Authors

Journals

citations
Cited by 42 publications
(41 citation statements)
references
References 24 publications
4
37
0
Order By: Relevance
“…In contrast, the effects of tyramine on blood flow during contractions were markedly attenuated, but not eliminated, during exercise intensities that closely matched the blood flow increases caused by the drug infusions. For example, tyramine infusions caused reductions in blood flow of ϳ10 -15% during heavy rhythmic handgrip exercise (81,128,130,385,386,479). These findings are summarized and illustrated in FIGURE 22.…”
Section: B Contraction Blunts Sympathetic Vasoconstrictionmentioning
confidence: 96%
See 1 more Smart Citation
“…In contrast, the effects of tyramine on blood flow during contractions were markedly attenuated, but not eliminated, during exercise intensities that closely matched the blood flow increases caused by the drug infusions. For example, tyramine infusions caused reductions in blood flow of ϳ10 -15% during heavy rhythmic handgrip exercise (81,128,130,385,386,479). These findings are summarized and illustrated in FIGURE 22.…”
Section: B Contraction Blunts Sympathetic Vasoconstrictionmentioning
confidence: 96%
“…In animal models and some human studies, NO has emerged as a mediator of sympatholysis, and there is evidence to both support and reject a role for it (90,128,129,155,467,479). However, administration of exogenous nitrovasodilators does not cause sympatholysis (81,386). To date, exogenous administration of ATP does mimic the sympatholytic effects of contraction on sympathetic vasoconstriction (252,387,388), and this is also one of the primary arguments favoring ATP as a major player in exercise hyperemia.…”
Section: B Contraction Blunts Sympathetic Vasoconstrictionmentioning
confidence: 99%
“…At present, neither adenosine nor prostaglandins appear to be obligatory for functional sympatholysis (20,34,69,90,93). In contrast, a study in humans has implicated local tissue hypoxia as an important factor in the attenuated vasoconstrictor response to SNA in exercising muscle (34).…”
Section: Mechanisms Underlying Functional Sympatholysismentioning
confidence: 95%
“…Consequently, the increase in exercise hyperemia with PDE5 inhibition in older subjects (26) could also reflect that a lower cGMP level during exercise was, at least in part, related to a diminished NO bioavailability. As opposed to the reports on the vascular effects of ATP, consistent evidence has been provided to support that NO is neither sufficient nor essential for functional sympatholysis in humans (9,31,33,41). Consequently, an NO-mediated increase in local vasodilation in the contracting leg muscles would, therefore, be expected to be independent of an improved ability for functional sympatholysis.…”
mentioning
confidence: 88%
“…As the vasodilator effect of NO is mediated via cGMP (35), one mechanism underlying the increase in exercise hyperemia with PDE5 inhibition in older subjects (26) could be an improved cGMP signaling, which would serve to potentiate the effect of NO and thereby compensate for a diminished NO bioavailability. Notably, pharmacological inhibition of NO synthesis does not impact the ability of contracting forearm muscles to blunt vasoconstrictor responses to tyramine as well as ␣ 1 -and ␣ 2 -adrenoceptor agonists (7,9) and infusion of SNP also fails to blunt vasoconstrictor responses to tyramine and ␣ 1 -and ␣ 2 -adrenoceptor agonists in the forearm (33,41). Furthermore, infusion of ascorbic acid increases NO-mediated vasodilation in the exercising forearm of older individuals without improving functional sympatholysis (31).…”
Section: Effect Of Pde5 Inhibition On Plasma [Atp] and Functional Symmentioning
confidence: 99%